#ExpeditionRNA
LightNews LightNews
handle.invalid
Arrakis Founder and CSO Jennifer Petter presents the first data for our lead drug program using our proprietary platform to develop RNA-targeted small molecule (rSMs) medicines today at the #CellSymposia. #ExpeditionRNA

arrakistx.com/wp-content/u...
December 4, 2024 at 12:32 PM
handle.invalid
Today at the #CellSymposia, we present the first preclinical data for our RNA-targeted small molecule (rSM) drug program showing reversal of myotonia in myotonic dystrophy Type 1 (DM1), a form of muscular dystrophy. We’re excited to advance our program. #ExpeditionRNA
arrakistx.com/press-releas...
December 4, 2024 at 11:47 AM
handle.invalid
We’re welcoming 2025 at Arrakis, committed to pioneering a new class of genetic medicines: RNA-targeted small molecules (rSMs). We’re looking ahead to new milestones and to building relationships with new partners this year. #ExpeditionRNA

arrakistx.com
January 3, 2025 at 3:33 PM
handle.invalid
Data we present today at the #CellSymposia for our first RNA-targeted small molecule (rSM) drug program supports additional product development with our multi-modality rSM drug platform. We aim to broaden the reach of genetic medicine with oral drugs. #ExpeditionRNA
arrakistx.com/press-releas...
December 4, 2024 at 12:43 PM
handle.invalid
This week and all year, we’re thankful for our phenomenal team and grateful for each Arrakeen and their commitment to each other and our mission. They exemplify two of our core values – thriving as a team and being inspired by each other. Happy Thanksgiving to all. #ExpeditionRNA
November 27, 2024 at 2:50 PM
handle.invalid
Our CEO Michael Gilman @gilman.bsky.social, CSO Jennifer Petter and CBO James Mutamba will be in San Francisco for the JPM conference next week, Jan 13-16. Looking forward to great meetings and connections! #ExpeditionRNA #JPM2025
January 7, 2025 at 3:12 PM
handle.invalid
In an oral presentation at the MDA Clinical & Scientific Conference next week, we will present preclinical data for our lead, rationally designed, RNA-targeted small molecule drug program for treatment of myotonic dystrophy type 1 (DM1). #MDAconference #ExpeditionRNA
arrakistx.com/press-releas...
March 10, 2025 at 12:17 PM
handle.invalid
Arrakeens gathered for an end-of-year party to celebrate the accomplishments and hard work of this year. We’re looking forward to more milestones in 2025. #ExpeditionRNA
December 20, 2024 at 3:17 PM
handle.invalid
Happy #RNADay! Today we celebrate all things RNA, the foundation of our mission to create rSMs (RNA-targeted small molecules) that act directly on RNA to treat disease.

#ExpeditionRNA
August 1, 2025 at 1:28 PM
handle.invalid
Today at the 2nd Biophysics for Drug Discovery Summit in Boston, Griffin Schroeder, Scientist II, will present on our work to target RNA for new small molecule (rSM) medicines. #ExpeditionRNA #ArrakeensInAction
March 27, 2025 at 3:39 PM
handle.invalid
A capstone to 2024 was our presentation of preclinical data this month for the first RNA-targeted small molecule (rSM) drug program we’re advancing to treat DM1, a form of muscular dystrophy. As we enter 2025, we’ve reached an inflection point and we can’t stop now. #ExpeditionRNA
arrakistx.com
December 16, 2024 at 4:46 PM
handle.invalid
Our CSO Jennifer Petter shares her expertise today as facilitator on “RNA as a Drug Target: Breakthroughs and Challenges in Small Molecule Approaches” at the 2024 Medicinal Chemistry Strategy Meeting.
#MedicinalChemistry #SmallMolecules #ExpeditionRNA #BioSky
www.linkedin.com/posts/medici...
Medicinal Chemistry Strategy Meeting on LinkedIn: #medicinalchemistry #rnaresearch #drugdiscovery #smallmolecules…
We are thrilled to welcome Dr. Jennifer Petter, Founder & Chief Scientific Officer of Arrakis Therapeutics, as one of the esteemed facilitators at the…
www.linkedin.com
November 13, 2024 at 4:43 PM
handle.invalid
Happy #RNADay! Tomorrow we celebrate all things RNA, the foundation of our mission to create rSMs (RNA-targeted small molecules) that act directly on RNA to treat disease.

#ExpeditionRNA
July 31, 2026 at 3:28 PM
handle.invalid
Our CEO Michael Gilman and CBO James Mutamba will be in San Francisco for the JPM conference next week, Jan 12-15. Looking forward to great meetings and connections, and we hope to see you there!

#ExpeditionRNA #JPM2026
January 6, 2026 at 2:36 PM
handle.invalid
We’re welcoming 2026 with renewed focus. Our team remains committed to advancing RNA-targeted medicines and continuing the important work ahead. Wishing all a bright, healthy start to the new year!

#ExpeditionRNA
January 5, 2026 at 3:08 PM
handle.invalid
Our team gathered for a casual holiday get-together, sharing food, laughter, and a chance to appreciate the incredible people behind our mission. Our gingerbread house creations were truly inspired and festive! Grateful for this team today and every day.

#ExpeditionRNA
December 22, 2025 at 5:13 PM
handle.invalid
Our CEO Michael Gilman and CBO James Mutamba will be in San Francisco for the JPM conference next month, Jan 12-15, 2026. Looking forward to great meetings and connections!

#ExpeditionRNA #JPM2026
December 15, 2025 at 2:39 PM
handle.invalid
This week we slow down and express gratitude for our phenomenal team and their commitment to each other, our core values, and our mission.

Happy Thanksgiving to all.

#ExpeditionRNA
November 25, 2025 at 2:14 PM
handle.invalid
Today, we join the world in recognizing UNESCO World #ScienceDay. This year’s theme: ‘Trust, Transformation, and Tomorrow: The Science We Need for 2050’ makes us excited about our mission to change the way challenging diseases are treated. #ExpeditionRNA
Learn more: www.unesco.org/en/days/scie...
November 10, 2025 at 2:44 PM
handle.invalid
Monday at the HBM Biopharma Summit 2025 in Zurich, our Chief Business Officer James Mutamba will give a corporate presentation and Arrakis overview.

#ExpeditionRNA
September 19, 2025 at 1:58 PM
handle.invalid
Our CEO Michael Gilman will share his experiences and discuss what it takes to scale innovation for lasting impact during a fireside chat today at the BioPort Atlantic 2025 conference in Halifax.

#ExpeditionRNA
September 17, 2025 at 1:29 PM
handle.invalid
To celebrate #RNADay at Arrakis, we constructed our own ‘Arrakis RNA’ made with RNA codons that translate into amino acids that represent us, whether it be one of our initials or our favorite letter, and what we can create as a team!

#ExpeditionRNA #WeAreArrakeen
August 5, 2025 at 1:55 PM
handle.invalid
It’s #ImmigrantHeritageMonth, and we are proud of our backgrounds and the cultural diversity on #ExpeditionRNA.

We recognize the important role that immigrants play in our success at Arrakis and our communities. #DareToBeArrakeen
June 10, 2025 at 1:58 PM
handle.invalid
Today our CSO Jennifer Petter joins the hosts of the Drug Hunter Flash Talk, an ongoing series of talks about drug discovery, for a discussion of drugging RNA with small molecules.
#ExpeditionRNA

Listen here:
drughunter.com/flashtalks?u...
May 29, 2025 at 1:38 PM
handle.invalid
We’re honored to be named winner of the #CitelineAwards 2025 for Most Successful Early Phase Research (Preclinical & Phase I) at last night’s event! Thank you to Citeline and to every member of our team for their hard work and dedication. Congratulations to all nominees and winners! #ExpeditionRNA
May 9, 2025 at 4:18 PM